Your browser doesn't support javascript.
loading
A Mansonone Derivative Coupled with Monoclonal Antibody 4D5-Modified Chitosan Inhibit AKR1C3 to Treat Castration-Resistant Prostate Cancer.
Zhou, Meng; Wang, Xiaoyu; Xia, Jie; Cheng, Yating; Xiao, Lichun; Bei, Yu; Tang, Jianzhong; Huang, Yadong; Xiang, Qi; Huang, Shiliang.
Afiliación
  • Zhou M; Institute of Biomedicine and Guangdong Provincial Key Laboratory of Bioengineering Medicine, Jinan University, Guangzhou 510632, People's Republic of China.
  • Wang X; Institute of Biomedicine and Guangdong Provincial Key Laboratory of Bioengineering Medicine, Jinan University, Guangzhou 510632, People's Republic of China.
  • Xia J; School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, People's Republic of China.
  • Cheng Y; Institute of Biomedicine and Guangdong Provincial Key Laboratory of Bioengineering Medicine, Jinan University, Guangzhou 510632, People's Republic of China.
  • Xiao L; Institute of Biomedicine and Guangdong Provincial Key Laboratory of Bioengineering Medicine, Jinan University, Guangzhou 510632, People's Republic of China.
  • Bei Y; Biopharmaceutical R&D Center of Jinan University, Guangzhou 510630, People's Republic of China.
  • Tang J; Biopharmaceutical R&D Center of Jinan University, Guangzhou 510630, People's Republic of China.
  • Huang Y; Institute of Biomedicine and Guangdong Provincial Key Laboratory of Bioengineering Medicine, Jinan University, Guangzhou 510632, People's Republic of China.
  • Xiang Q; Biopharmaceutical R&D Center of Jinan University, Guangzhou 510630, People's Republic of China.
  • Huang S; Institute of Biomedicine and Guangdong Provincial Key Laboratory of Bioengineering Medicine, Jinan University, Guangzhou 510632, People's Republic of China.
Int J Nanomedicine ; 15: 3087-3098, 2020.
Article en En | MEDLINE | ID: mdl-32431503
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Terapia Molecular Dirigida / Neoplasias de la Próstata Resistentes a la Castración / Miembro C3 de la Familia 1 de las Aldo-Ceto Reductasas / Antineoplásicos Límite: Animals / Humans / Male Idioma: En Revista: Int J Nanomedicine Año: 2020 Tipo del documento: Article Pais de publicación: Nueva Zelanda
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Terapia Molecular Dirigida / Neoplasias de la Próstata Resistentes a la Castración / Miembro C3 de la Familia 1 de las Aldo-Ceto Reductasas / Antineoplásicos Límite: Animals / Humans / Male Idioma: En Revista: Int J Nanomedicine Año: 2020 Tipo del documento: Article Pais de publicación: Nueva Zelanda